82P Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Pacira Biosciences Inc

Watchlist Manager

Watchlist

Price: 28.28 EUR

Market Cap: €1.3B

P	Pacira Biosciences Inc XBER:82P	US
	Komeda Holdings Co Ltd OTC:KMDHF	JP
F	FirstEnergy Corp SWB:FE7	US
P	Panasonic Holdings Corp SWB:MAT1	JP
	Aviva PLC OTC:AIVAF	UK
	China Resources Beer Holdings Co Ltd F:CHK	HK
	Pepkor Holdings Ltd OTC:PPKRF	ZA
G	GE Vernova LLC BMV:GEV	US
	Cantaloupe Inc NASDAQ:CTLP	US
W	Wabash National Corp F:WA9	US
L	Life Healthcare Group Holdings Ltd XBER:L53	ZA
	Yamada Holdings Co Ltd OTC:YMDAF	JP
Q	Quanta Services Inc SWB:QAA	US
	D'Ieteren Group NV F:DJDA	BE
K	Kinross Gold Corp LSE:0R2D	CA
S	Standard Chartered PLC OTC:SCBFY	UK
R	Resona Holdings Inc DUS:DW1	JP
P	PDS Biotechnology Corp F:EU6	US
C	Commerzbank AG XBER:CBK	DE
C	Commerzbank AG DUS:CBK	DE
C	Cameco Corp XMUN:CJ6	CA

Profitability Summary

Pacira Biosciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

79%

Strong 3Y Average Gross Margin

75%

Gross Margin is Increasing

68% > 79%

Low Operating Margin

Sustainable 3Y Average Operating Margin

11%

Declining Operating Margin

9% > 5%

Low Net Margin

Negative 3Y Average Net Margin

-2%

Net Margin is Increasing

-2% > 1%

Exceptional Free Cash Flow Margin

18%

Strong 3Y Average Free Cash Flow Margin

20%

Free Cash Flow Margin is Increasing

16% > 18%

Low ROE

Negative 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.